Cultured AFB Antitubercular DST Clarithromycin Test
Comprehensive Tuberculosis Drug Sensitivity Testing
The Cultured AFB Antitubercular DST Clarithromycin Test represents a critical advancement in tuberculosis management, providing healthcare professionals with essential data to combat drug-resistant TB strains. This specialized diagnostic procedure evaluates the effectiveness of clarithromycin against Mycobacterium tuberculosis complex, enabling personalized treatment strategies for patients facing this challenging infectious disease.
What This Test Measures and Detects
This sophisticated laboratory analysis specifically measures the sensitivity of Mycobacterium tuberculosis complex isolates to clarithromycin antibiotic concentrations. The test employs automated fluorescent technology to determine:
- Minimum inhibitory concentrations (MIC) of clarithromycin against TB bacteria
- Presence of clarithromycin-resistant tuberculosis strains
- Bacterial growth patterns at various antibiotic concentrations
- Effectiveness of clarithromycin as part of combination therapy
Who Should Consider This Test
This test is particularly important for individuals experiencing:
- Persistent cough lasting more than three weeks
- Unexplained weight loss and night sweats
- Fatigue and general malaise with respiratory symptoms
- Previous TB treatment failure or relapse
- Exposure to drug-resistant tuberculosis cases
- Immunocompromised conditions increasing TB susceptibility
- Travel history to TB-endemic regions
Key Benefits of Clarithromycin Sensitivity Testing
Undergoing this specialized testing provides numerous advantages for both patients and healthcare providers:
- Personalized Treatment Planning: Enables physicians to design targeted antibiotic regimens based on individual bacterial sensitivity profiles
- Reduced Treatment Failure: Identifies resistant strains early, preventing ineffective treatment courses
- Prevention of Resistance Spread: Helps contain drug-resistant TB strains within communities
- Cost-Effective Care: Avoids unnecessary medication expenses by confirming drug effectiveness
- Improved Patient Outcomes: Increases treatment success rates through evidence-based antibiotic selection
Understanding Your Test Results
Your test results will provide clear guidance on clarithromycin effectiveness:
- Sensitive Result: Indicates clarithromycin effectively inhibits bacterial growth, making it a viable treatment option
- Resistant Result: Shows the TB strain is not responsive to clarithromycin, requiring alternative antibiotic selection
- Intermediate Sensitivity: Suggests partial effectiveness, which may require combination therapy or adjusted dosing
Your physician will interpret these results in the context of your overall health status and develop a comprehensive treatment plan tailored to your specific needs.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $112 |
| Regular Price | $162 |
Nationwide Testing Accessibility
We maintain comprehensive testing facilities across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible tuberculosis testing services for patients nationwide.
Schedule Your Test Today
Take control of your tuberculosis treatment journey with precise drug sensitivity testing. Our experienced medical team is ready to assist you in obtaining accurate diagnostic information for optimal treatment outcomes. Contact us today to schedule your Cultured AFB Antitubercular DST Clarithromycin Test.
Call or WhatsApp: +1(267) 388-9828
Our dedicated healthcare professionals will guide you through the testing process and answer any questions about tuberculosis diagnosis and treatment options.

